Review Article

Treatment and case fatality rate of COVID-19 in Africa

Ben Bepouka, Patricia Bandubuila Kaja, Hippolyte Situakibanza
Journal of Public Health in Africa | Vol 13, No 3 | a418 | DOI: https://doi.org/10.4081/jphia.2022.1931 | © 2024 Ben Bepouka, Patricia Bandubuila Kaja, Hippolyte Situakibanza | This work is licensed under CC Attribution 4.0
Submitted: 11 April 2024 | Published: 07 September 2022

About the author(s)

Ben Bepouka, Service of Infectious Diseases, Department of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Congo, the Democratic Republic of the
Patricia Bandubuila Kaja, Service of Infectious Diseases, Department of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Congo, the Democratic Republic of the
Hippolyte Situakibanza, Service of Infectious Diseases, Department of Internal Medicine, Kinshasa University Hospital, University of Kinshasa, Congo, the Democratic Republic of the

Full Text:

PDF (2MB)

Abstract

In Africa, the treatment of COVID-19 depends on each country. Several protocols are observed with real results that we described in this study. The objective of this review was to describe the treatment of COVID-19 and the case fatality rate in African countries, by reviewing the literature on treatment and case fatality in African countries whose data was available through the internet during the writing period until February 7, 2021. The majority of African countries had a treatment based on hydroxychloroquine or chloroquine + azithromycin, used in varying doses depending on the country. The lethality in Africa remains low compared to European and American countries. The same treatment being used in some northern countries does not fully explain the low case fatality.


Keywords

treatment; case fatality; COVID 19; Africa

Metrics

Total abstract views: 290
Total article views: 30


Crossref Citations

No related citations found.